Patient type (CKD stage)
|
Treatments for anemia
|
Year 4 Total costs ($)
|
---|
Without SEB
|
With SEB
|
---|
Stage III/IV
|
Short acting ESA (SC)
|
38,308,544
|
25,996,178
|
Long acting ESA (SC)
|
39,849,400
|
27,041,803
|
Epoetin SEB
|
-
|
13,411,903
|
Stage V
|
Short acting ESA (SC)
|
29,148,598
|
19,780,239
|
Long acting ESA (SC)
|
20,185,070
|
13,697,588
|
Short acting ESA (IV)
|
119,750,354
|
81,262,590
|
Long acting ESA (IV)
|
83,272,569
|
56,508,765
|
Epoetin SEB
|
-
|
43,304,392
|
Total
|
330,514,535
|
281,003,457
|
- SEB = subsequent entry biologic; CKD = chronic kidney disease; ESA = erythropoiesis stimulating agents; SC = subcutaneous; IV = intravenous.